Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (161-170 of 357) with videos related to

Pageof 36
Sort By:
Clinical Lung Cancer|February 25, 2016
The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Benjamin Besse, Julie Renee Brahmer, et al.
Anticancer Research|July 28, 2004
Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use programCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Treatment of advanced non-small-cell lung cancer in the elderlyCesare Gridelli, Paolo Maione, Antonio Rossi, et al.
Anticancer Research|October 30, 2016
Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell LinesRita Ambrosio, Maria Neve Ombra, Cesare Gridelli, et al.
The Oncologist|May 29, 2009
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Annals of Translational Medicine|December 22, 2022
Diabetic ketoacidosis induced by nivolumab in invasive mucinous adenocarcinoma of the lung: a case report and review of the literatureJuan Yan, Zheng-Zheng Xie, Teresa Moran, et al.
Tumori|May 7, 2002
Chemotherapy of advanced NSCLC in the elderlyCesare Gridelli, Carmine Ferrara, Filomena Del Gaizo, et al.
Reviews on Recent Clinical Trials|March 31, 2016
Overcoming Resistance to EGFR Inhibitors in NSCLCPaolo Maione, Paola C Sacco, Francesca Casaluce, et al.
Cancer|September 24, 2004
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderlyCesare Gridelli, Erminia Massarelli, Paolo Maione, et al.
Anticancer Research|March 16, 2004
Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical caseAntonio Rossi, Giuseppe Colantuoni, Nicola Cantore, et al.
Pageof 36

Showing results (161-170 of 357) with videos related to

Sort By:
Pageof 36
Clinical Lung Cancer|February 25, 2016
The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Benjamin Besse, Julie Renee Brahmer, et al.
Anticancer Research|July 28, 2004
Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use programCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Treatment of advanced non-small-cell lung cancer in the elderlyCesare Gridelli, Paolo Maione, Antonio Rossi, et al.
Anticancer Research|October 30, 2016
Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell LinesRita Ambrosio, Maria Neve Ombra, Cesare Gridelli, et al.
The Oncologist|May 29, 2009
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Annals of Translational Medicine|December 22, 2022
Diabetic ketoacidosis induced by nivolumab in invasive mucinous adenocarcinoma of the lung: a case report and review of the literatureJuan Yan, Zheng-Zheng Xie, Teresa Moran, et al.
Tumori|May 7, 2002
Chemotherapy of advanced NSCLC in the elderlyCesare Gridelli, Carmine Ferrara, Filomena Del Gaizo, et al.
Reviews on Recent Clinical Trials|March 31, 2016
Overcoming Resistance to EGFR Inhibitors in NSCLCPaolo Maione, Paola C Sacco, Francesca Casaluce, et al.
Cancer|September 24, 2004
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderlyCesare Gridelli, Erminia Massarelli, Paolo Maione, et al.
Anticancer Research|March 16, 2004
Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical caseAntonio Rossi, Giuseppe Colantuoni, Nicola Cantore, et al.
Pageof 36